Benzinga | Nov 23, 2020 07:47AM EST

Morgan Stanley Initiates Coverage On Biodesix with Overweight Rating, Announces Price Target of $20

Morgan Stanley initiates coverage on Biodesix (NASDAQ:BDSX) with a Overweight rating and announces Price Target of $20.